twenty-three middle-aged men ( 59 +/- 2 years ) with sustained , essential hypertension ( who stage ii ) and with diastolic blood pressure exceeding 100 mmhg during a run-in placebo month were included in a trial designed to assess the clinical and haemodynamic effects of isradipine , a novel dihydropyridine calcium antagonist .
C0071304
isradipine
C2945601
dihydropyridine calcium